Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Open in API
Filings indexed 309 across all filing types
Latest filing 2024-08-05 Regulatory Filings
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Board Meeting — NGL FINE-CHEM LIMITED has informed the Exchange about Board Meeting to be held on 12-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the…
Regulatory Filings
2024-08-05 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchanges about the upcoming Second Board Meeting of the company for the financial year 2024-25. It specifically mentions the agenda to approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2024. The document is a formal announcement of a meeting date and agenda, not the financial results report itself. The length is short (1601 characters), and it serves as a notification rather than containing substantive financial data or analysis. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, rather than an Interim Report (IR) or Earnings Release (ER).
2024-08-05 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement about the dispatch of the Notice to Shareholders for the 43rd Annual General Meeting (AGM), book closure, and final dividend. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements. The document itself is short (1469 characters) and does not contain the actual AGM notice or detailed meeting materials, but rather informs about the advertisement publication. This fits the description of a Report Publication Announcement (RPA), as it announces the availability or dispatch of a report (the AGM notice) rather than containing the report itself.
2024-08-02 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement for the 43rd Annual General Meeting (AGM), book closure, and final dividend. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and encloses copies of the newspaper advertisement. The document is short (1568 characters) and serves as a notice or announcement rather than the AGM materials themselves or the dividend declaration details. It does not contain financial statements or detailed report content. Therefore, it fits the category of a Report Publication Announcement (RPA), as it announces the publication of a notice related to the AGM and dividend but is not the report or notice itself.
2024-07-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding compliance with Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the issuance of a "Letter of Confirmation" to shareholders in lieu of lost share certificates. The content is about share certificate replacement and compliance notification to the exchanges. It does not contain financial data, management discussion, or report content. It is a regulatory compliance announcement related to shareholding records and not a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended June 30, 2024. It includes details of share certificates dematerialized and confirms compliance with regulatory requirements. The document is a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or management discussion but is a regulatory compliance filing. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3768 characters, which is relatively short and consistent with a certificate or confirmation letter rather than a full report.
2024-07-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.